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Background/aim: The objective of this study was to examine the effect of addition of subanesthetic doses of ketamine to an epinephrinelidocaine solution on postoperative pain, analgesic use, and patient comfort during rhinoplasties.
Materials and methods: Ninety patients were randomly divided into three groups: Group L, lidocaine with epinephrine; Group K,
lidocaine with epinephrine plus ketamine; and Group S (control group), physiological saline solution with epinephrine. The local
anesthetic solution was injected as preincisionally with intranasal submucosal infiltration following induction of general anesthesia. We
evaluated visual pain score, analgesic demand, Wilson sedation score, and antiemetic demand at 5, 15, and 30 min and 1, 2, 4, 6, 8, 16,
and 24 h after the operation. The patient satisfaction score was checked 24 h after the operation.
Results: Visual pain score was significantly reduced in Group K in comparison with the other groups and this group did not need any
rescue analgesics (P < 0.05). The postoperative patient satisfaction scores were highest in Group K compared with the other groups (P
< 0.05).
Conclusion: Addition of ketamine solution to lidocaine for infiltration block during rhinoplasty was successful in decreasing pain
during postoperative periods and reducing analgesic consumption during the first 24 h after the operation.
Key words: Ketamine, lidocaine, rhinoplasty, postoperative pain

1. Introduction
Rhinoplasty is a reconstructive surgery that is frequently
performed to correct nasal deformities. Local anesthesia
alone or local and general anesthesia together can be used
in this procedure. Patients experience distinct pain for 3
days after the operation, which is especially severe during
the first day (1). Good analgesia should be provided
during the postoperative period in order to ensure patient
compliance and comfort (2). Local anesthesia is frequently
used because it also contributes to analgesia. The addition
of vasoconstrictors and adjuvant agents to local anesthetics
reduces side effects and facilitates analgesic effect and
duration with reduced local anesthetic concentrations.
Epinephrine increases the duration of local anesthesia and
provides good exposure (3). Agents such as neostigmine,
clonidine, or opioids may also be added to increase
the duration of anesthesia. However, neostigmine and
opioids are not suited for rhinoplasties because they may
cause nausea and vomiting, and clonidine is unavailable
in many countries (4,5). Therefore, ketamine and its
* Correspondence: mukaddersanli@gmail.com

enantiomers are frequently used in multimodal anesthesia
approaches. Ketamine has been shown to be better among
other adjuvant agents in terms of efficacy and safety,
pharmacokinetics, and pharmacodynamics (6).
Ketamine allows preventative analgesia via
2 mechanisms: central desensitization due to
antihyperalgesic effect and pain control as an N-methyl-daspartate antagonist. It has been shown that preincisional
infiltration anesthesia with subanesthetic ketamine
increases block time, thereby decreasing postoperative
analgesic demand (7). The use of ketamine alone as a
preventative analgesic remains questionable (8,9).
Lidocaine-epinephrine combinations are used
frequently in addition to general anesthesia for intranasal
infiltration during rhinoplasty, but, to date, there is no
published study on the effect of added ketamine. The
objective of our study was to determine the usefulness of
subanesthetic ketamine as an adjuvant to the infiltration
block in terms of postoperative pain scores, analgesic
demand, and patient satisfaction.
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2. Materials and methods
2.1. Ethics consideration
This study was approved by the Malatya Clinical Studies
Ethics Board (2012/130, Malatya, Turkey). The study was
registered with the Clinical Trials Registry, NCT01827020
(https://clinicaltrials.gov/). Written and oral consent was
obtained from all patients. Ninety ASA class I patients who
were scheduled for rhinoplasty under general anesthesia
were included. Exclusion criteria are the following:
systemic diseases (hypertension, diabetes, coronary artery
and valve disease), drug allergy, psychiatric disorders,
chronic pain, and chronic alcohol intake.
2.2. Patients and controls
Patients were randomly divided into three groups by
closed envelope method and were instructed to fast for at
least 8 h prior to surgery. Upon arrival for surgery, routine
monitoring (electrocardiogram, heart rate, pulse oximeter,
noninvasive arterial blood pressure) was initiated
following intravenous (I.V.) cannulation and 0.03 mg/kg
I.V. midazolam premedication. Anesthesia induction was
provided with fentanyl (1 to 2 µg/kg) and propofol (2 to 3
mg/kg). Patients were intubated after myorelaxation with
rocuronium (0.6 mg/kg). Anesthesia maintenance was
achieved with 2% to 3% of sevoflurane and 60% nitrous
oxide in O2.
Patients in Group L received 1 mg/kg lidocaine
(Arythmal 2%, 5 mL amp, Osel®, İstanbul, Turkey) + 0.0125
mg/mL epinephrine; in Group K 1 mg/kg lidocaine + 0.5
mg/kg ketamine (racemic ketamine, Ketalar 500 mg vial,
Pfizer®, İstanbul) + 0.0125 mg/mL epinephrine; and in
group S 0.0125 mg/mL epinephrine completed with saline
to a total of 12 mL. Intranasal submucosal infiltration
volume was administered in all groups and surgery was
started 5 min after local infiltration. The plastic surgeons
and anesthetists were blinded to the contents of the
injections for each patient. Myorelaxation was reversed
with 0.05 mg/kg neostigmine and 0.02 mg/kg atropine
following the return of spontaneous respiration at the end
of each surgery.
An increase of >30% in systolic arterial pressure from
baseline was treated with 100 µg/kg nitroglycerine and a
decrease of >30% was treated with 10 mg of ephedrine.
Bradycardia (heart rate of <50 beats/min) was treated with
0.5 mg of atropine sulfate.
2.3. Postoperative evaluation
After extubation, patients were evaluated 5, 15, and 30
min and 1, 2, 4, 6, 8, 16, and 24 h after the operation. Pain
was evaluated using a visual pain score (VPS) of 0 to 100,
where 0 indicated no pain and 100 indicated unbearable
pain, and 8 mg of lornoxicam (Xefo® I.V., 2 mL vial, A.İ.
İstanbul) was administered if the VPS was ≥40. When
nausea or vomiting occurred, patients were treated with
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chlorpropamide (1 mL amp, Primperan®). Sedation was
monitored via the Wilson sedation scale, where 1 =
fully awake and oriented, 2 = drowsy, 3 = eyes closed but
rousable to command, 4 = eyes closed but rousable to mild
physical stimulation, and 5 = eyes closed and unrousable
to mild physical stimulation. Patients were also checked
for hallucination and dizziness. Patient satisfaction
was evaluated 24 h after the operation using a patient
satisfaction score where 1 = low satisfaction, 2 = medium,
3 = good, and 4 = excellent.
2.4. Statistical analysis
The postoperative VPS at 30 min was considered the
primary endpoint and was used to estimate the sample size
of 30 patients in each group with 80% power to detect a
10% difference in the VPS between Group S, Group L, and
Group K. Data were recorded and calculated using SPSS
13.0 for Windows version. Results of continuous variables
were expressed as mean, standard deviation, and median
(min–max) and categorical variables were expressed as
number and percent. Normality for continuous variables
in groups was determined with the Shapiro–Wilk test. The
Unpaired t-test, paired t-test, Wilcoxon test, and one-way
analysis of variance (ANOVA) were used for statistical
analysis. A value of P < 0.05 was considered significant.
3. Results
The patients were similar in terms of age, height, weight,
sex, and operation times. Patient data are summarized in
Table 1. There were no statistically significant differences
among the groups in terms of mean arterial pressure,
SpO2, and heart rate. There were no cases of bradycardia
or hypertension throughout the study
The VPS values in Group S were significantly higher
than in the other groups at 15 min and 8 h after the
operations (P = 0.0001 and P = 0.000, respectively). The
VPS values in Group L were significantly higher than in
the other groups at 30 min and 16 h after the operations
(respectively P = 0.001 and P = 0.000; Table 2).
There was no difference in nausea and vomiting
among the three groups (Table 3). Patients in Group K
had no postoperative analgesic demands, but this was
not statistically significant (P = 0.093; Table 4). The rate
of demand for antiemetics as determined at the end of
the 24-h postoperative period in each group was 10% (3
patients) in Group L, 10% (3 patients) in Group K, and
6.7% (2 patients) in Group S.
The Wilson sedation score at 5 and 15 min was 2 for all
patients in Group L; in Group K, 7 patients (23.3%) had
Wilson score = 1, 22 (73.3%) had Wilson score = 2, and
1 (3.3%) had Wilson score = 4. In Group S, 15 patients
(50%) had Wilson score = 1 and 15 (50%) had Wilson
score = 2. At 30 min, 25 patients (83.3%) in Group L had
reached Wilson score 1 and 5 (16.7%) had Wilson score
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Table 1. Demographic characteristics.
Group L
(n = 30)

Group K
(n = 30)

Group S
(n = 30)

Age (years)

26.6 ± 4.9

25.8 ± 4.8

26.1 ± 5.3

Height (cm)

168.4 ± 8.6

166.4 ± 9.2

167.4 ± 8.0

Weight (kg)

64.8 ± 9.1

61.1 ± 11.1

65.4 ± 10.5

Sex (F/M)

18/12

22/8

21/9

Duration of surgery (min)

89.0 ± 11.2

90.5 ± 9.7

90.8 ± 7.6

Data are expressed as mean ± SD and sex as number.

Table 2. Visual pain score (VPS 0 to 100) in each group.
Group L
(n = 30)

Group K
(n = 30)

Group S
(n = 30)

P-value

VPS, 5 min

20 (10–40)

10 (10–20)

30 (30–70)

0.057

VPS, 15 min

30 (20–70)

10 (10–20)

70 (30–80)*

0.000

VPS, 30 min

60 (30–70)#

10 (10–20)

20 (20–30)

0.001

VPS, 1 h

30 (20–70)

10 (10–20)

20 (20–30)

0.062

VPS, 2 h

20 (20–30)

15 (10–30)

20 (20–30)

0.990

VPS, 4 h

20 (20–30)

20 (10–20)

20 (20–30)

0.300

VPS, 6 h

20 (20–30)

20 (10–20)

20 (20–30)

0.109

VPS, 8 h

20 (20–70)

15 (10–30)

70 (20–80)*

0.001

VPS, 16 h

60 (30–70)#

20 (10–60)

20 (20–70)

0.000

VPS, 24 h

20 (20–30)

20 (10–20)

20 (20–30)

0.011

VPS presented as median value (min–max) in each group. #Group L compared with Group K
and Group S. *Group S compared with Group L and Group K.

Table 3. Postoperative nausea and vomiting in each group.
Nausea / Vomiting
Group L (n = 30)

Nausea / Vomiting
Group K (n = 30)

Nausea / Vomiting
Group S (n = 30)

5 min

7 (23.3%) / 11 (36.7%)

8 (26.7%) / 1 (3.3%)

1 (36.7%) / 2 (6.7%)

15 min

-/-

-/-

11(36.7%) / 2 (6.7%)

30 min

(3.3%) / -

- /-

9 (3%0) / 6 (20%)

1h

5 (16.7%)/ 5 (16.7%)

-/-

-/-

2, 4, 6, 8, 16, and 24 h

-/-

-/-

-/-

Data are presented as number (percentage).
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Table 4. Need of analgesics in each group.
Group L
(n = 30)
None

-

Group K
(n = 30)

Group S
(n = 30)

30 (100%)*

-

One time

3 (10%)

-

26 (86.7%)

Two times

12 (40%)

-

22 (73.3%)

Need of analgesics presented as number (percentage).
*There was no requirement for analgesics in Group K.

2; 26 (86.7%) were at Wilson score 1 in Group K, 3 (10%)
were at Wilson score 2, and 1 (3.3%) was at Wilson score 3.
At 1 h postoperatively, all patients in all groups were fully
awake (Wilson score = 1), and all remained so throughout
the remainder of the 24-h observation period.
Three patients (10%) in Group K experienced
hallucinations 30 min postoperatively. Hallucinations were
not recorded at any other time during the observation
period in this group, and no patient in Group L or Group
S experienced hallucination at any time. Dizziness was not
reported for any patient in any group.
The patient satisfaction score was significantly higher in
Group K compared to either of the other groups (Table 5).
4. Discussion
Our results demonstrated that the addition of 0.5 mg/kg
ketamine to lidocaine with an epinephrine solution in
patients undergoing rhinoplasty under general anesthesia
provides effective postoperative analgesia with decreased
analgesic demand during the first 24 h after the operation.
These results were accompanied by higher patient
satisfaction scores.
Local anesthetic combinations with epinephrine
are frequently used in many surgeries, including nasal
Table 5. Patient satisfaction scores in each group.
Score

Group L
(n = 30)

Group K
(n = 30)

1

2 (6.7%)

2

17 (56.7%)

5 (16.7%)

19 (63%)

3

11 (36.7%)

21 (70%)*

6 (20%)

4

-

4 (13.3%)

-

-

Group S
(n = 30)
5 (16.7%)

Data are presented as number of patients (percent) with
satisfaction of patient score ( 1 = low, 2 = medium, 3 = good,
and 4 = excellent).
*Satisfaction of patients is seen to be highest in Group K.
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surgeries, in order to provide good exposure, increase
the duration of local anesthesia, and decrease the toxic
side effects of local anesthetics (10). Demiraran et al.
compared levobupivacaine and epinephrine-added
lidocaine infiltration anesthesia in nasal surgeries, similar
to our study, and determined that in addition to giving
better exposure, postoperative analgesic consumption was
significantly decreased (11). Addition of vasoconstrictors
also offers the important advantage of decreasing the
systemic toxic effects of the local anesthetic agent.
Thevasagayam et al. found that using lidocaine infiltration
anesthesia during rhinoplasty decreased systemic
absorption of cocaine, thereby decreasing cardiac side
effects while allowing safe increases of the cocaine dose (3).
Significant decreases in VPS and analgesic use have also
been reported during the first 24 h after septorhinoplasty
operations in which naphazoline nitrate, a vasoconstrictor
derivative, was used in combination with lidocaine (12).
In the present study, there was no demand for analgesics
in Group L until 30 min postoperatively, and the level of
analgesic consumption in this group was lower than that
observed in the control group.
Combined preincisional local anesthetics can be used
during general anesthesia or sedation. Infiltration block
provides good intraoperative and postoperative analgesia
when the anesthetic method is selected properly. In
adolescents, a lidocaine and bupivacaine combination was
administered preincisionally, and despite its use with the
accompanying midazolam and fentanyl sedation, general
anesthesia was required for most of the patients (9 out of
14) (13). In addition, when Jha et al. compared 0.5 mg/
kg ketamine and 2 mg/kg bupivacaine preincisionally
with epinephrine in palate repair of children following
general anesthesia, they found, similar to our study, that
postoperative pain scores (CHEOPS) and analgesic demand
were significantly lower in the ketamine group (14).
Providing preemptive analgesia in parallel to the
development of multimodal analgesia has gained
importance. If pain transmission is stopped prior to
incision, morbidity decreases along with the intensity and
duration of postoperative pain (15). Ketamine is not used
in pain treatment, but it enables effective postoperative
analgesia via N-methyl-d-aspartate antagonism and by
changing central sensitization. The antihyperalgesic effect
of peripheral local ketamine has been shown in preclinical
studies (16). Subanesthetic or low-dose ketamine (1
mg/kg) decreases postoperative analgesic consumption
at a significant level without any side effects due to its
analgesic effectiveness along with a proven harmony
with local anesthetics and opioids (17). Doses of 0.5 and
1 mg ketamine were examined in a study of peritonsillar
ketamine infiltration carried out by Honarmand et al., and
because those authors did not find a difference between
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the doses in terms of preventing postoperative pain over
24 h, we used the 0.5 mg dose in our study (18). Savafi
et al. used preincisional subcutaneous infiltration or I.V.
ketamine to provide preemptive analgesia for patients
undergoing cholecystectomy (19). Similar to our study,
they determined that analgesia was attained during the
first 24 h after the operation without any significant side
effects. In fact, the local anesthetic effect of ketamine may
last for as long as 1 week, but in the present study, we did
not determine the absolute duration of the analgesic effect
because our postoperative observation period ended at 24
h (20).
The subcutaneous, oral, rectal, topical, intranasal,
sublingual, I.V., I.M., epidural, and caudal analgesic effect
of ketamine were determined in a review by Tawfic (21).
Yeaman et al. effectively used subanesthetic ketamine
with an intranasal atomizer device (22). Analgesia was
obtained in 56% of patients with 0.7 and 1 mg/kg ketamine
administration due to decreased absorption of ketamine
(30%–50%). Analgesia was obtained in all patients of our
study with submucosal administration of the medications.
Surendar et al. topically administered ketamine in a higher
dose (5 mg/kg) to the nasal cavity with an intranasal
syringe in pediatric dental patients. They achieved better
postoperative analgesia with ketamine compared to
midazolam and dexmedetomidine (23).
The efficacy of a ketamine and ropivacaine combination
used in caudal blocks has also been examined. In a study of
2 mg/kg ropivacaine and 0.5 mg/kg ketamine administered

in combination during the preoperative period in children
undergoing inguinal hernia repair, it was determined
that in addition to providing hemodynamic stability, the
combination was associated with significantly increased
analgesic duration and decreased analgesic use (24).
Although those authors used ketamine in neuraxial
blocks, in contrast to the submucosal block examined in
the present study, our patients in the ketamine group also
had significant reductions in VPS values and decreased
analgesic consumption, in addition to hemodynamic
stability, without any negative side effects.
The limitations of our study were as follows.
First, local anesthetic with epinephrine was used in all
three groups in our study, and hemoglobin and hematocrit
were not monitored as a primary objective of our study
of analgesia. Next, because the process of acquiring
permission for the use of drugs for indications outside of
the prospective scope is long, we did not include a group
where only ketamine infiltration was used. The use of
ketamine as infiltration anesthesia in rhinoplasty should
be supported by further studies, and the effects on bleeding
and pain control should also be further examined.
In conclusion, an infiltration block in addition to
general anesthesia in rhinoplasties can be used successfully
without any intraoperative or postoperative side effects.
When ketamine is used as the adjuvant agent, it provides
effective analgesia during the first 24 h after the operation,
and it decreases analgesic use and increases patient
comfort.
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